Zhong Liu

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 14

Top Topics

Machine Learning

Respiratory Syndrome Coronavirus

Top Venues

Transfusion medicine (Oxford, England)

Scientific reports

This page only lists publications with an associated author ORCID identifier.

Publications

Ling Li, Rui Wang, Jin Guo, Liu He, Zhengmin Liu, Qianqian Qin, Jing Zhang, Shuo Wu, Liqin Huang, Hongwei Ge, Zhong Liu
Suggested blood donor deferral strategy regarding hepatitis B infections in China. Transfusion medicine (Oxford, England) 34 (2) (2024)
Yudi Xie, Yang Xia, Haixia Xu, Jue Wang, Wei Zhang, Ling Li, Zhong Liu
Analysis of related factors of plasma antibody levels in patients with severe and critical COVID-19. Scientific reports 14 (1) (2024)
Yudi Xie, Yang Xia, Haixia Xu, Jue Wang, Wei Zhang, Ling Li, Zhong Liu
Analysis of related factors of plasma antibody levels in patients with severe and critical COVID-19. Scientific reports 14 (1) (2024)
Ling Li, Rui Wang, Jin Guo, Liu He, Zhengmin Liu, Qianqian Qin, Jing Zhang, Shuo Wu, Liqin Huang, Hongwei Ge, Zhong Liu
Suggested blood donor deferral strategy regarding hepatitis B infections in China. Transfusion medicine (Oxford, England) (2024)
Yudi Xie, Yang Xia, Haixia Xu, Jue Wang, Wei Zhang, Ling Li, Zhong Liu
Analysis of related factors of plasma antibody levels in patients with severe and critical COVID-19. Scientific reports 14 (1) (2024)
Ling Li, Rui Wang, Jin Guo, Liu He, Zhengmin Liu, Qianqian Qin, Jing Zhang, Shuo Wu, Liqin Huang, Hongwei Ge, Zhong Liu
Suggested blood donor deferral strategy regarding hepatitis B infections in China. Transfusion medicine (Oxford, England) 34 (2) (2024)
Feng Lin, Yi Huang, Xu He, Zhong Liu
Research on the socioeconomic factors that influence the development of voluntary, non-remunerated blood donation in China-A correlation and regression analysis based on data from 2012 to 2018. Health science reports 6 (7) (2023)
Xue Tian, Yujie Kong, Jue Wang, Rui He, Ling Li, Zhong Liu, null null
Development of the Chinese Haemovigilance Network and reporting of adverse transfusion reactions from 2018 to 2020. Vox sanguinis 117 (8) (2022)
Rui He, Jue Wang, Zhenmeng Wang, Yu Liu, Haixia Xu, Xuejun Zhang, E Deng, Yundi Yin, Xin Ji, Xiaoyu Guan, Qi Ren, Caixia Wu, Yongjun Chen, Ling Li, Wei Zhang, Zhong Liu
A possible dose-response equation: Viral load after plasma infusion in COVID-19 patients and anti-SARS-CoV-2 antibody titers in convalescent plasma. Transfusion medicine (Oxford, England) 32 (2) (2022)
Ling Li, Lynn G Stansbury, John R Hess, Zhong Liu
The first transfusions in China. Transfusion 60 (5) (2020)
Yundi Yin, Ling Li, Li Gong, Haixia Xu, Zhong Liu
Effects of riboflavin and ultraviolet light treatment on pathogen reduction and platelets. Transfusion 60 (11) (2020)
Ling Li, Xunliang Tong, Hanwei Chen, Rui He, Qilu Lv, Ru Yang, Lei Zhao, Jue Wang, Haixia Xu, Chuanqiao Liu, Guoan Chen, Sitian Chen, Chenyue Li, Jiajia Qiao, Juntao Yang, Yanyun Wu, Zhong Liu
Characteristics and serological patterns of COVID-19 convalescent plasma donors: optimal donors and timing of donation. Transfusion 60 (8) (2020)
Ling Li, Ru Yang, Jue Wang, Qilu Lv, Ming Ren, Lei Zhao, Hanwei Chen, Haixia Xu, Songli Xie, Jin Xie, Hui Lin, Wenjuan Li, Peng Fang, Li Gong, Lan Wang, Yanyun Wu, Zhong Liu
Feasibility of a pilot program for COVID-19 convalescent plasma collection in Wuhan, China. Transfusion 60 (8) (2020)
Jiajia Qiao, Rui He, Yonghua Yin, Li Tian, Ling Li, Zhengqiu Lian, Peng Fang, Zhong Liu
rIL-35 prevents murine transfusion-related acute lung injury by inhibiting the activation of endothelial cells. Transfusion 60 (7) (2020)